0.1901
0.19 (-1.80%)
As of Jun 14, 2022
Salarius Pharmaceuticals, Inc. [SLRX]
Source:
Company Overview
Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical need. Specifically, we are developing treatments for cancers caused by dysregulated gene expression, i.e., genes which are incorrectly turned on or off.
Country | United States |
Headquarters | houston, texas |
Phone Number | 346-772-0346 |
Industry | manufacturing |
CEO | David J. Arthur |
Website | www.salariuspharma.com |